$8B Risperdal Verdict Slashed To $6.8M

Law360 (January 17, 2020, 1:21 PM EST) -- A Philadelphia County judge agreed Friday to cut an $8 billion punitive damages verdict against a Johnson & Johnson subsidiary to $6.8 million in a landmark case over side effects associated with the antipsychotic drug Risperdal.

The $8 billion punitive damages verdict followed a trial on claims that Johnson & Johnson unit Janssen Pharmaceuticals obscured data showing a link between Risperdal and abnormal breast growth in boys. (AP)

Judge Kenneth Powell in the Philadelphia County Court of Common Pleas sided with arguments from J&J unit Janssen Pharmaceuticals Inc. that the $8 billion in damages returned in October was outsized when compared with...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!